OMED

OncoMed Pharmaceuticals, Inc.
OMED

Overview Fund Activity
Delisted

OMED was delisted on the 22nd of April, 2019.

Back to rankings

69 hedge funds and large institutions have $83.9M invested in OncoMed Pharmaceuticals, Inc. in 2017 Q4 according to their latest regulatory filings, with 16 funds opening new positions, 22 increasing their positions, 20 reducing their positions, and 5 closing their positions.

Holders
69
Holders Change
+11
Holders Change %
+18.97%
% of All Funds
1.57%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
16
Increased
22
Reduced
20
Closed
5
Calls
$3K
Puts
–
Net Calls
+$3K
Net Calls Change
-$70K

Top Buyers

1
BI
1
BVF Inc
California
$17.5M
2
PA
2
Perceptive Advisors
New York
$10.7M
3
Millennium Management
3
Millennium Management
New York
$2.23M
4
CM
4
Crestline Management
Texas
$753K
5
ECM
5
Endurant Capital Management
California
$570K

Top Sellers

1
ASP
1
Adams Street Partners
Illinois
$2.01M
2
BlackRock
2
BlackRock
New York
$919K
3
IHM
3
Iguana Healthcare Management
New York
$615K
4
CS
4
Candriam SCA
Luxembourg
$1.31M
5
PP
5
PDT Partners
New York
$242K
Name Market Value Shares Shares
Change 		Shares
Change %
Primecap Management
1
Primecap Management
California
$22.8M 5,565,600 -300 -0%
BI
2
BVF Inc
California
$17.5M 4,271,289 +4,271,289 New
PA
3
Perceptive Advisors
New York
$10.7M 2,620,897 +1,582,608 +152%
Vanguard Group
4
Vanguard Group
Pennsylvania
$4.09M 998,147 -29,417 -3%
Ameriprise
5
Ameriprise
Minnesota
$3.94M 961,137 +49,953 +5%
Millennium Management
6
Millennium Management
New York
$2.23M 543,335 +324,845 +149%
Renaissance Technologies
7
Renaissance Technologies
New York
$2.17M 529,300 +117,700 +29%
Alyeska Investment Group
8
Alyeska Investment Group
Illinois
$2.14M 521,883 – –
ASP
9
Adams Street Partners
Illinois
$2.01M 490,707 -982,354 -67%
CS
10
Candriam SCA
Luxembourg
$1.31M 320,000 -50,000 -14%
DGI
11
Disciplined Growth Investors
Minnesota
$1.29M 314,465 +690 +0.2%
CC
12
Cannell & Co
New York
$1.25M 303,971 – –
D.E. Shaw & Co
13
D.E. Shaw & Co
New York
$1.15M 280,930 +122,914 +78%
BlackRock
14
BlackRock
New York
$919K 224,157 -568,181 -72%
First Eagle Investment Management
15
First Eagle Investment Management
New York
$900K 219,420 – –
CM
16
Crestline Management
Texas
$753K 183,687 +183,687 New
Norges Bank
17
Norges Bank
Norway
$748K 182,357 – –
Bank of America
18
Bank of America
North Carolina
$628K 153,196 +311 +0.2%
IHM
19
Iguana Healthcare Management
New York
$615K 150,000 -200,000 -57%
ECM
20
Endurant Capital Management
California
$570K 139,100 +139,100 New
Axa
21
Axa
France
$540K 131,785 +30,006 +29%
Geode Capital Management
22
Geode Capital Management
Massachusetts
$481K 117,330 -7,239 -6%
BCM
23
Bridgeway Capital Management
Texas
$332K 80,900 -8,000 -9%
AG
24
Algert Global
California
$266K 64,989 +64,989 New
Two Sigma Investments
25
Two Sigma Investments
New York
$252K 61,365 +37,205 +154%
1
2 3 4